Virtual Event on School ReopeningAs schools start to reopen across the country, how can parents, students, and households living with cystic fibrosis make the best decisions for them around distance and in-person learning? Join us virtually on Thursday, July 30, at 7 p.m. ET for a discussion with clinical experts in the field and have a chance to have your questions answered.
Register now »
| |
COVID-19 Q&A Updated to Address School Reopening
| |
Positive Phase 3 Results of Trikafta Provide Further Evidence of Efficacy
Vertex released positive Phase 3 results for Trikafta® for people with cystic fibrosis ages 12 and older who have one copy of the F508del mutation and one gating or residual function mutation. While people with these mutations are already approved for Trikafta in the U.S., the results provide further evidence of the efficacy of the triple-combination therapy for this group and could help inform decisions about whether to switch modulators.
Read the announcement »
| |
Five Financial Tips for the COVID-19 EraCOVID-19 has created emotional and financial uncertainty for many people living with cystic fibrosis and their families. Susanne’ Muenzel, LCSW, a pediatric CF social worker, shares her tips to help with some of those challenges, including how to stretch your stimulus and food budget to the max and how to make a financial plan.
Read the blog »
| |
|
|
|
|
